Basic Information
Mozart Therapeutics, Inc. is a new biopharmaceutical company developing CD8 Treg cell modulators for the treatment of autoimmune and inflammatory diseases. The lead program focuses on autoimmune-mediated gastrointestinal disorders.
Mozart Therapeutics, Inc.
Seattle,Washington,United States of America
unclear
January 01, 2020
contact@mozart-tx.com